Pharmacogenetic Dosing of Warfarin

NCT02065388 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
300
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Academia Sinica, Taiwan

Collaborators